MicroRNA-138 inhibits hypoxia-inducible factor 1α expression in breast cancer cells

Area of Science:

• Oncology
• Molecular Biology
• Gene Regulation

Background:

• Hypoxia is a critical factor in cancer development, stabilizing hypoxia-inducible factor 1-alpha (HIF-1α).
• HIF-1α activation promotes breast cancer progression, including metastasis and therapeutic resistance.
• MicroRNAs (miRNAs) are known regulators of gene expression in cancer, including tumorigenesis.

Purpose of the Study:

• To investigate the regulatory role of miRNAs on HIF-1α expression in breast cancer cells.
• To identify specific miRNAs that are deregulated under hypoxic conditions and their effect on HIF-1α.
• To explore the potential of targeting these miRNAs for breast cancer therapy.

Main Methods:

• Culturing MCF-7 and MDA-MB-231 breast cancer cells under normoxia and hypoxia.
• Characterizing miRNA expression profiles using TaqMan-Low Density Array (TLDA).
• Validating miRNA-HIF-1α interactions using luciferase reporter assays and lentiviral transduction.

Main Results:

• Hypoxia deregulated 12 miRNAs in MCF-7 cells and 16 miRNAs in MDA-MB-231 cells.
• miR-138 was found to be downregulated in both cell lines under hypoxia.
• miR-138 directly binds to the 3'UTR of HIF-1α and downregulates its expression.

Conclusions:

• miR-138 plays a significant role in regulating HIF-1α expression under hypoxic conditions.
• Downregulation of miR-138 contributes to HIF-1α stabilization and potential breast cancer progression.
• Targeting miR-138 presents a promising therapeutic strategy to reduce HIF-1α and inhibit breast cancer invasion and metastasis.